Also on Trial Friend:Dermatomyositis pageMatch Me
All 36 Dermatomyositis trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOMost sites in Kansas, Missouri and TexasRecruitingPhase 1Ages 18+National Cancer Institute (NCI)40US sites
14 states - A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)Most sites in Texas, Florida and ColoradoRecruitingPhase 3Ages 18-75AstraZeneca34US sites
18 states - RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory MyopathyMost sites in Illinois, New York and PennsylvaniaRecruitingPhase 2/3Ages 6-75Cabaletta Bio31US sites
19 states - Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)Most sites in Texas, California and MarylandRecruitingPhase 1Ages 18-85Chugai Pharmaceutical7US sites
6 states - A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory MyopathiesMost sites in Texas and ArizonaRecruitingPhase 3Ages 18+Pfizer3US sites
2 states - Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune DisordersMost sites in District of Columbia, Missouri and OhioRecruitingPhase 1/2Ages 12+Cartesian Therapeutics3US sites
3 states - Adult and Juvenile MyositisMost sites in Maryland and North CarolinaRecruitingAges 2-100National Institute of Environmental Health Sciences (NIEHS)2US sites
2 states - Environmental Risk Factors for the Anti-synthetase SyndromeMost sites in Maryland and North CarolinaRecruitingAges 2-100National Institute of Environmental Health Sciences (NIEHS)2US sites
2 states - Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)Only in FloridaRecruitingPhase 2/3Ages 18+Restem, LLC.2US sites
- Study of KYV-101 Anti-CD19 CAR T Therapy in Adult DermatomyositisOnly in CaliforniaRecruitingPhase 1Ages 25-72Stanford University2US sites
- A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101Only in ColoradoRecruitingAges 18+Kyverna Therapeutics1US site
- Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)Only in PennsylvaniaRecruitingAges 18+University of Pennsylvania1US site
- Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) StudyOnly in FloridaRecruitingPhase 2Ages 18+University of Miami1US site
- FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)Only in MarylandRecruitingPhase 2Ages 18-62National Institute of Environmental Health Sciences (NIEHS)1US site
- Intralesional Injection of STS in Treatment of CalcinosisOnly in PennsylvaniaRecruitingPhase 2Ages 18+Robyn T. Domsic, MD, MPH1US site
- MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)Only in LouisianaRecruitingAges 7+Myositis International Health & Research Collaborative Alliance Foundation1US site
- Rheumatology Diet StudyOnly in FloridaRecruitingAges 18-65University of Central Florida1US site
- Rheumatology Patient Registry and BiorepositoryOnly in ConnecticutRecruitingAges 18-99Yale University1US site
- Topical Ruxolitinib Cream for Refractory Cutaneous DermatomyositisOnly in OhioRecruitingPhase 2Ages 18-89The Cleveland Clinic1US site
- Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune DiseasesRecruitingPhase 1/2Ages 18-65Fondazione Policlinico Universitario Agostino Gemelli IRCCSNo US site yet
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Dermatomyositis trials in the US, and what stage they are in
Of the 21 Dermatomyositis trials with a US site, 4 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 9 of them. The remaining 8 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 8 of them, and universities, hospitals, foundations and government groups run 13. National Institute of Environmental Health Sciences (NIEHS) runs the most, with 3. The most recently listed one first appeared on ClinicalTrials.gov on July 28, 2026.
Dermatomyositis trials in the US, state by state
Of the 21 Dermatomyositis trials with a US site, 7 accept children under 18. Their open sites are in 22 states and Washington, DC, most often North Carolina, Maryland and Massachusetts. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 19 states
US hospitals running the most Dermatomyositis trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Dermatomyositis.
- National Institutes of Health Clinical CenterBethesda, Maryland3 trials
- NIEHS Clinical Research Unit (CRU)Research Triangle Park, North Carolina2 trials
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - GlendaleGlendale, Arizona1 trial
- Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile PatientsChicago, Illinois1 trial
- Arthritis & Rheumatology Research Institute, PLLCFrisco, Texas1 trial
- Austin Neuromuscular CenterAustin, Texas1 trial
- Bioresearch PartnerMiami, Florida1 trial
- Boston Children's HospitalBoston, Massachusetts1 trial
- Boston Children's Hospital - Accepting Young Adults and Juvenile PatientsBoston, Massachusetts1 trial
- Children's Healthcare of Atlanta - Accepting Juvenile PatientsAtlanta, Georgia1 trial
Help getting to a Dermatomyositis trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding a Dermatomyositis trial near you
Are there Dermatomyositis clinical trials near me?
As of November 13, 2026, 36 Dermatomyositis clinical trials are recruiting now and 6 are not yet recruiting. In the US, 21 of them have at least 1 open site, across 28 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Dermatomyositis clinical trial sites?
Recruiting Dermatomyositis trials list open sites in 28 states and Washington, DC. Maryland, North Carolina and Pennsylvania have the most, and the table on this page lists every state.
Are there Dermatomyositis trials for children near me?
Of the 21 Dermatomyositis trials with a US site, 7 accept children under 18. Their open sites are in 22 states and Washington, DC, most often North Carolina, Maryland and Massachusetts. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to a Dermatomyositis clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.
What if there is no Dermatomyositis trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Dermatomyositis trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Dermatomyositis: Lisraya (brepocitinib), Acthar Gel (repository corticotropin injection), Corticosteroids (prednisone, prednisolone, methylprednisolone, dexamethasone, hydrocortisone, betamethasone, triamcinolone), Immune globulin (immune globulin (human)).
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.